|
|
|
Insider
Information: |
Kolchinsky Peter |
Relationship: |
Director, 10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
21 |
|
Direct
Shares |
6,648,738 |
|
Indirect Shares
|
89,615,900 |
|
|
Direct
Value |
$30,628,641 |
|
|
Indirect Value
|
$932,125,367 |
|
|
Total
Shares |
96,264,638 |
|
|
Total
Value |
$962,754,008 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
14.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aradigm Corp |
ARDM |
10% Owner |
2007-03-01 |
0 |
2008-01-15 |
7,681,410 |
Premium* |
|
Curis Inc |
CRIS |
10% Owner |
2008-04-15 |
0 |
2008-04-15 |
6,250,564 |
Premium* |
|
Sequenom Inc |
SQNM |
10% Owner |
|
0 |
2008-06-06 |
4,617,766 |
Premium* |
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-12-29 |
0 |
2009-04-14 |
825,844 |
Premium* |
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2008-03-27 |
0 |
2008-03-27 |
3,705,312 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2013-09-30 |
4,816,562 |
2014-09-11 |
13,000,000 |
Premium* |
|
Sangamo Biosciences Inc |
SGMO |
Former 10% Owner |
2014-08-01 |
1,829,426 |
2013-07-17 |
0 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-07 |
0 |
2015-10-21 |
2,314,942 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
Director, 10% Owner |
2016-10-31 |
0 |
2020-04-02 |
0 |
Premium* |
|
Kalvista Pharmaceuticals Inc |
KALV |
Director, 10% Owner |
2016-11-21 |
0 |
2017-10-12 |
1,441,070 |
Premium* |
|
G1 Therapeutics Inc |
GTHX |
Fmr 10% Owner See Foot... |
2017-05-22 |
0 |
2017-05-22 |
2,684,244 |
Premium* |
|
Kala Pharmaceuticals, Inc. |
KALA |
Director, 10% Owner |
2017-07-25 |
0 |
2020-03-13 |
10,874,613 |
Premium* |
|
Wave Life Sciences Ltd. |
WVE |
Director, 10% Owner |
2017-11-13 |
0 |
2019-01-24 |
7,775,207 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2017-12-18 |
0 |
2019-12-02 |
0 |
Premium* |
|
Eidos Therapeutics, Inc. |
EIDX |
10% Owner |
2018-06-22 |
0 |
2018-06-22 |
2,162,671 |
Premium* |
|
Arvinas Holding Company, Llc |
ARVN |
Former 10% Owner |
2018-10-01 |
0 |
2018-10-01 |
3,138,412 |
Premium* |
|
Synthorx, Inc. |
THOR |
Director, 10% Owner |
2018-12-11 |
0 |
2020-01-23 |
0 |
Premium* |
|
Satsuma Pharmaceuticals, Inc. |
STSA |
Former 10% Owner |
2019-09-17 |
0 |
2023-06-08 |
0 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
|
0 |
2019-10-16 |
5,422,312 |
Premium* |
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director, 10% Owner |
2021-06-17 |
2,750 |
2021-06-17 |
9,011,651 |
Premium* |
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
|
0 |
2020-12-10 |
8,709,882 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
207 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-10 |
4 |
S |
$15.67 |
$53,326 |
D/D |
(3,403) |
4,606,641 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-10 |
4 |
B |
$14.91 |
$1,237,339 |
D/D |
83,000 |
4,610,044 |
2.44 |
- |
|
SQNM |
Sequenom Inc |
10% Owner |
|
2008-06-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,617,766 |
|
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-05-22 |
4 |
S |
$13.51 |
$764,537 |
D/D |
(56,396) |
4,632,557 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-28 |
4 |
B |
$13.29 |
$995,014 |
D/D |
74,844 |
4,650,172 |
2.44 |
- |
|
STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
|
2019-09-17 |
4 |
B |
$15.00 |
$19,999,995 |
I/I |
1,333,333 |
4,681,858 |
1.5 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-05-13 |
4 |
S |
$13.12 |
$735,305 |
D/D |
(56,060) |
4,688,953 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-14 |
4 |
S |
$14.78 |
$45,165 |
D/D |
(3,055) |
4,720,578 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-16 |
4 |
S |
$14.09 |
$307,658 |
D/D |
(21,829) |
4,720,578 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-11 |
4 |
B |
$14.48 |
$1,694,299 |
D/D |
116,992 |
4,723,633 |
2.44 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-15 |
4 |
B |
$13.10 |
$287,206 |
D/D |
21,829 |
4,742,407 |
2.44 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
Director |
|
2018-01-05 |
4 |
D |
$9.15 |
$165,544 |
I/I |
(18,100) |
4,742,913 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-05-12 |
4 |
S |
$13.01 |
$386,330 |
D/D |
(29,659) |
4,745,013 |
0 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
Director |
|
2018-01-04 |
4 |
D |
$9.20 |
$711,910 |
I/I |
(77,400) |
4,761,013 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-17 |
4 |
B |
$14.02 |
$581,959 |
D/D |
41,500 |
4,762,078 |
2.44 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-04-30 |
4 |
B |
$13.29 |
$1,674,679 |
D/D |
124,500 |
4,774,672 |
2.44 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-05-08 |
4 |
S |
$12.39 |
$1,032,587 |
D/D |
(83,300) |
4,774,672 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-30 |
4 |
B |
$3.50 |
$5,432,000 |
D/D |
1,552,000 |
4,816,562 |
2.45 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-05-07 |
4 |
B |
$11.71 |
$557,989 |
D/D |
47,564 |
4,822,236 |
2.44 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-11 |
4 |
S |
$7.30 |
$283,240 |
D/D |
(38,800) |
4,828,817 |
0 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
Director |
|
2018-01-03 |
4 |
D |
$9.25 |
$546,870 |
I/I |
(59,100) |
4,838,413 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-11 |
4 |
B |
$7.18 |
$279,069 |
D/D |
38,800 |
4,848,217 |
2.45 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-12 |
4 |
S |
$7.27 |
$136,996 |
D/D |
(18,857) |
4,848,760 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-12 |
4 |
B |
$7.20 |
$135,796 |
D/D |
18,857 |
4,856,521 |
2.45 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
|
2014-05-07 |
4 |
B |
$12.09 |
$431,870 |
D/D |
35,736 |
4,857,972 |
2.44 |
- |
|
207 Records found
|
|
Page 6 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|